BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 705267)

  • 21. [Penicillamine-induced polymyositis (author's transl)].
    Bettendorf U; Neuhaus R
    Dtsch Med Wochenschr; 1974 Dec; 99(49):2513, 2522-5. PubMed ID: 4548017
    [No Abstract]   [Full Text] [Related]  

  • 22. D-penicillamine-induced polymyositis occurring in patients with rheumatoid arthritis: a report of two cases and demonstration of a positive lymphocyte stimulation test to D-penicillamine.
    Matsumura T; Yuhara T; Yamane K; Kono I; Kabashima T; Kashiwagi H
    Henry Ford Hosp Med J; 1986; 34(2):123-6. PubMed ID: 3489699
    [No Abstract]   [Full Text] [Related]  

  • 23. [D-penicillamine-induced pemphigus, polymyositis and myasthenia].
    Jan V; Callens A; Machet L; Machet MC; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1999 Feb; 126(2):153-6. PubMed ID: 10352832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymyositis with acute myolysis in a patient with rheumatoid arthritis treated with penicillamine and ampicillin.
    Ostensen M; Husby G; Aarli J
    Arthritis Rheum; 1980 Mar; 23(3):375-7. PubMed ID: 7362693
    [No Abstract]   [Full Text] [Related]  

  • 25. D-penicillamine induced polymyositis causing complete heart block.
    Wright GD; Wilson C; Bell AL
    Clin Rheumatol; 1994 Mar; 13(1):80-2. PubMed ID: 8187449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutaneous problems with drug therapy in rheumatoid arthritis.
    Wilson CL; Bradlow A; Wojnarowska F
    Int J Dermatol; 1991 Feb; 30(2):148-9. PubMed ID: 2001908
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiple side effects of penicillamine therapy in one patient with rheumatoid arthritis.
    Essigman WK
    Ann Rheum Dis; 1982 Dec; 41(6):617-20. PubMed ID: 6216862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D-penicillamine and polymyositis: the significance of the anti-Jo-1 antibody.
    Jenkins EA; Hull RG; Thomas AL
    Br J Rheumatol; 1993 Dec; 32(12):1109-10. PubMed ID: 8252325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-penicillamine and immune complex deposition.
    Kirby JD; Dieppe PA; Huskisson EC; Smith B
    Ann Rheum Dis; 1979 Aug; 38(4):344-6. PubMed ID: 159020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuromuscular disorders associated with D-penicillamine treatment for rheumatoid arthritis.
    Devogelaer JP; Isaac G; Noël H; De Bruyère M; Huaux JP; Nagant de Deuxchaisnes C
    Int J Clin Pharmacol Res; 1985; 5(3):143-7. PubMed ID: 4018948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penicillamine induced myositis: correlation between urinary zinc excretion and serum creatine.
    Jimenez-Balderas FJ; Rangel J; Mintz G
    J Rheumatol; 1991 Jun; 18(6):945-7. PubMed ID: 1895284
    [No Abstract]   [Full Text] [Related]  

  • 32. D-Penicillamine--induced pemphigus syndrome.
    Yung CW; Hambrick GW
    J Am Acad Dermatol; 1982 Mar; 6(3):317-24. PubMed ID: 7068961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dermatopolymyositis induced by D-penicillamine in rheumatoid polyarthritis. Apropos of 1 case with review of the literature].
    Kolsi R; Bahloul Z; Hachicha J; Gouiaa R; Jarraya A
    Rev Rhum Mal Osteoartic; 1992 May; 59(5):341-4. PubMed ID: 1411195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [D-penicillamine and dermatopolymyositis. Value of the study of anti-JO 1 antibodies].
    Oberlin F; Koeger AC; Meyer O; Rosey T; Camus JP
    Presse Med; 1986 May; 15(19):887. PubMed ID: 2940560
    [No Abstract]   [Full Text] [Related]  

  • 35. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Penicillamine-induced polymyositis.
    Machtey I; Cucher BG; Goldman AL
    Ann Intern Med; 1977 Jun; 86(6):832. PubMed ID: 869377
    [No Abstract]   [Full Text] [Related]  

  • 37. Polymyositis complicating D-penicillamine treatment.
    Aydintug AO; Cervera R; D'Cruz D; Ramírez G; Asherson RA; Khamashta MA; Hughes GR
    Postgrad Med J; 1991 Nov; 67(793):1018-20. PubMed ID: 1775410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Myasthenic syndrome during penicillamine treatment (author's transl)].
    Schumm F; Stöhr M
    Klin Wochenschr; 1978 Feb; 56(3):139-44. PubMed ID: 628198
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [D-penicillamine-induced pemphigus].
    Chouvet B; Thivolet J; Bathias J; Forestier JY
    Dermatologica; 1980; 160(5):297-310. PubMed ID: 7364140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stimulation single fiber EMG study in patients receiving a long-term D-penicillamine treatment for rheumatoid arthritis.
    Dominkus M; Grisold W; Albrecht G
    Muscle Nerve; 1992 Nov; 15(11):1300-1. PubMed ID: 1488070
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.